Literature DB >> 19407482

Identification of a novel kindred with familial pancreatitis and pancreatic cancer.

Jennifer LaFemina1, Penelope A Roberts, Yin P Hung, James F Gusella, Dushyant Sahani, Carlos Fernández-del Castillo, Andrew L Warshaw, Sarah P Thayer.   

Abstract

BACKGROUND/AIMS: Hereditary pancreatic cancer comprises about 10% of pancreatic cancer cases. Multiple causative mutations have been identified. Here we describe a pancreatitis/pancreatic cancer (P/PC) family, which demonstrates pancreatitis and pancreatic cancer resulting from an uncharacterized mutation.
METHODS: Family members completed evaluations to determine signs of mutation status. Select patients were screened for mutations associated with hereditary pancreatic diseases.
RESULTS: In generation II, 12 siblings exhibit 6 cases of pancreatitis, 3 pancreatic cancer, and 2 obligate carrier status. The average age at pancreatitis diagnosis of enrolled members is 32.5 years; average age at pancreatic cancer diagnosis is 59 years. There is no association with known cancer syndromes. Those affected generally present with mild epigastric pain, and CT scans demonstrate characteristic fatty infiltration of the pancreatic body and tail with sparing of the head and neck. Full sequence analysis of genes associated with hereditary pancreatic disease failed to demonstrate known mutations or polymorphisms.
CONCLUSION: Based upon pedigree evaluation and preliminary DNA analysis, we believe that the family members with P/PC carry a novel genetic mutation resulting in hereditary pancreatitis. This mutation is autosomal dominant, expressed with high penetrance, and is part of a unique hereditary syndrome that significantly increases pancreatic cancer risk. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19407482      PMCID: PMC3713708          DOI: 10.1159/000201553

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  29 in total

1.  Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis.

Authors:  A B Lowenfels; P Maisonneuve; D C Whitcomb; M M Lerch; E P DiMagno
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

2.  Familial pancreatic cancer.

Authors:  D K Bartsch
Journal:  Br J Surg       Date:  2003-04       Impact factor: 6.939

3.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.

Authors:  H Witt; W Luck; H C Hennies; M Classen; A Kage; U Lass; O Landt; M Becker
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

4.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).

Authors:  H F Vasen; N A Gruis; R R Frants; P A van Der Velden; E T Hille; W Bergman
Journal:  Int J Cancer       Date:  2000-09-15       Impact factor: 7.396

5.  SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis.

Authors:  R H Pfützer; M M Barmada; A P Brunskill; R Finch; P S Hart; J Neoptolemos; W F Furey; D C Whitcomb
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

6.  Very high risk of cancer in familial Peutz-Jeghers syndrome.

Authors:  F M Giardiello; J D Brensinger; A C Tersmette; S N Goodman; G M Petersen; S V Booker; M Cruz-Correa; J A Offerhaus
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

Review 7.  Pancreatic cancer biology and genetics.

Authors:  Nabeel Bardeesy; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

8.  Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds.

Authors:  Stephen J Rulyak; Albert B Lowenfels; Patrick Maisonneuve; Teresa A Brentnall
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

10.  Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.

Authors:  Kay L Pogue-Geile; Ru Chen; Mary P Bronner; Tatjana Crnogorac-Jurcevic; Kara White Moyes; Sally Dowen; Carol A Otey; David A Crispin; Ryan D George; David C Whitcomb; Teresa A Brentnall
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

View more
  4 in total

Review 1.  Current status of molecular markers for early detection of sporadic pancreatic cancer.

Authors:  Subhankar Chakraborty; Michael J Baine; Aaron R Sasson; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2010-10-01

2.  A concise review on the current understanding of pancreatic cancer stem cells.

Authors:  Arokia Priyanka Vaz; Moorthy P Ponnusamy; Parthasarathy Seshacharyulu; Surinder K Batra
Journal:  J Cancer Stem Cell Res       Date:  2014

Review 3.  Hereditary pancreatitis: current perspectives.

Authors:  Kara L Raphael; Field F Willingham
Journal:  Clin Exp Gastroenterol       Date:  2016-07-26

4.  McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report.

Authors:  Sébastien Gaujoux; Eric Pasmant; Caroline Silve; Nadia Mehsen-Cetre; Romain Coriat; Alexandre Rouquette; Bertrand Douset; Frédéric Prat; Karen Leroy
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.